Hims & Hers is a Strong Buy, as shares appear historically cheap due to temporary margin compression and regulatory concerns. Click here to read more.

Narrated by Common, HIms and Hers' 2026 Super Bowl ad highlights how income disparities shape health outcomes—and position ...

In less than two weeks, more than 120 million people are expected to tune into the biggest advertising moment of the year: ...

The telehealth company is back in the fourth quarter of the Big Game, a year after its weight-loss ad drew regulatory and ...

Last year, Hims & Hers put out a Super Bowl ad—the first for the telehealth giant—that sparked both support and outrage for the way it claimed that Big Pharma prices GLP-1s “ for profits, not patients ...

"We fully expect this will ruffle some feathers," Hims & Hers chief design officer, Dan Kenger, told Business Insider.

Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One company is taking them to the Super Bowl so that anyone can try them. Hims ...

It’s the biggest week of the quarter for earnings this week with plenty of big names set to report. This week we have Tesla, Microsoft, Apple, Meta Platforms, UnitedHealth Group, Exxon Mobil, Visa, ...

More than 7,000 Pima County ninth-graders won't be able to take career and technical-education classes next year following a decision by the Arizona Legislature. The state Senate and House voted to ...

A multinational Fortune 500 company which provides a range of engineering services plans to lay off dozens at its Charlottesville-area facility.